New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials

New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials

For the last half century, vitamin K antagonists (VKAs) have been used for treatment and prevention of venous thromboembolism and stroke prevention in patients with atrial fibrillation. However, their fragile pharmacokinetics, need for routine laboratory monitoring and dose adjustments complicated t...

Full description

Saved in:
Bibliographic Details
Main Author: Sung-Won Jang
Format: Article
Language:English
Published: Korean College of Helicobacter and Upper Gastrointestinal Research 2016-12-01
Series:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:
Thrombin
Factor Xa
Anticoagulants
Atrial fibrillation
Venous thromboembolism
Online Access:http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2016.16.4.178
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items